Gemigliptin tartrate exhibits potent anti-glycation properties. Gemigliptin tartrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications.

Information provided on this site is intended for use only for particular country. Products protected under valid patents are not manufacture, offered or supplied by CHEMCOPIA. The product information provided on this site is for general information purposes only and does not construed as commercial or approved product information. Consumers should not construe any information herein as medical advice or as a substitute, The Company and its affiliates accept no responsibility for the reliance on or use of any information contained herein. Reader understands and agrees to the foregoing as well as all terms and conditions of the Legal Statement.